Helen Hobbs

Helen Hobbs
Born 1952
Boston, Massachusetts, U.S.
Nationality American
Fields Internal Medicine, Molecular Genetics
Institutions University of Texas Southwestern Medical Center
Notable awards Breakthrough Prize in Life Sciences (2016)
Pearl Meister Greengard Prize (2015)
Heinrich Wieland Prize (2005)
Spouse Dr. Dennis K. Stone
Children 2

Helen Hobbs is a professor at the University of Texas Southwestern Medical Center, and a Howard Hughes Medical Institute investigator, who won a 2016 Breakthrough Prize in Life Sciences and the 2015 Pearl Meister Greengard Prize. She helped find that people with hypomorphic PCSK9 mutations had lower LDL levels, and were almost immune to heart disease. This discovery helped lead to cholesterol-lowering drugs that mimicked the effects of the PCSK9 mutations.[1] She sits on the board of directors at Pfizer.

Education

Hobbs graduated from Stanford University and went to medical school at Case Western Reserve University School of Medicine. She completed an internship in internal medicine at Columbia-Presbyterian Medical Center,[2] where she met her future husband who was her resident in the emergency room.[3] Together, Hobbs and her husband, Dr. Dennis Stone, moved to Dallas, Texas in 1982, where she completed her medical training at Parkland Memorial Hospital, including a one year stint as chief resident.

After residency, she chose to pursue research following the advice of Donald Seldin,[4] the chairman of medicine at UT Southwestern Medical Center, which is affiliated with Parkland. Hobbs took a research post-doctoral position studying lipoproteins at UT Southwestern in the laboratory of Michael S. Brown and Joseph L. Goldstein, future Nobel Prize in Medicine winners.

Research

In 1987 Hobbs joined the faculty of UT Southwestern Medical Center. In 1999, she co-founded the Dallas Heart Study with Dr. Jonathan Cohen with a grant from the Donald W. Reynolds Foundation.[5] This study takes genetic samples of thousands of people, representative of the population of Dallas, and correlates them to the subject's health metrics.

References

  1. "Breakthrough Prizes Give Top Scientists the Rock Star Treatment". The New York Times. November 8, 2015. Retrieved November 9, 2015.
  2. "Doctor & Faculty Profiles". UT Southwestern Medical Center. Retrieved 20 February 2016.
  3. Neill, Ushma S. "A conversation with Helen Hobbs". The Journal of Clinical Investigation. Retrieved 20 February 2016.
  4. Mooney, Michael J. "The Father of Dallas Medicine". D Magazine. Retrieved 20 February 2016.
  5. "Dallas Heart Study". UT Southwestern Medical Center. Retrieved 20 February 2016.


This article is issued from Wikipedia - version of the Sunday, February 21, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.